|
|
Market Status and Development Trend of Biotech Drugs |
MAO Kai-yun, YANG Lu, WANG Heng-zhe, CHEN Da-ming |
Shanghai Information Center for Life Sciences, Chinese Academy of Sciences, Shanghai 200031, China |
|
|
Abstract Thanks to the advantage of the characteristics of biotech drugs itself, biotech drugs is developing quickly. In the broader market, sales from biotechnology products are expected to account for 27% of the world's pharmaceutical sales by 2020, versus the current share of 22% in 2013. Roche is expected to remain the biggest player in the biotechnology space with sales increasing by $14.5bn to $43.5bn in 2020, representing an annual growth of 6% per annum. In support of the government, China have formed industrial clusters based on the Chinese medicine group as the leading. While total market of Chinese biotechnology drugs accounted for the global market is only 2%, but future is larger. At present China has formed industrial clusters,the biggest player of which is Sinopharm. With the increased demand for disease treatment, Biotech drugs has huge developing potential, the market will further expand.
|
Received: 18 November 2014
Published: 25 January 2015
|
|
|
|
[1] EvaluatePharma. World Preview 2014, Outlook to 2020. [2014-11-5]. http://www.evaluategroup.com/public/Reports/EvaluatePharma-World-Preview-2014.aspx.
[2] 波士顿咨询公司.在中国打造世界领先的创新型生物技术药物产业. [2014-11-10]. http://www.bcg.com.cn/cn/newsandpublications/publications/reports/report20130130001.html.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|